Clover Health Investments Corp (NASDAQ: CLOV) kicked off on Friday, down -6.74% from the previous trading day, before settling in for the closing price of $2.82. Over the past 52 weeks, CLOV has traded in a range of $0.61-$3.82.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 52.25% over the past five years. While this was happening, its average annual earnings per share was recorded 71.11%. With a float of $375.64 million, this company’s outstanding shares have now reached $393.27 million.
Let’s look at the performance matrix of the company that is accounted for 552 employees. In terms of profitability, gross margin is 18.33%, operating margin of -7.26%, and the pretax margin is -7.57%.
Clover Health Investments Corp (CLOV) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Healthcare Plans Industry. The insider ownership of Clover Health Investments Corp is 24.49%, while institutional ownership is 14.74%. The most recent insider transaction that took place on Aug 09 ’24, was worth 999,596. In this transaction Director of this company bought 531,700 shares at a rate of $1.88, taking the stock ownership to the 1,409,267 shares. Before that another transaction happened on Jun 17 ’24, when Company’s Director bought 877,567 for $1.14, making the entire transaction worth $1,000,426. This insider now owns 877,567 shares in total.
Clover Health Investments Corp (CLOV) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 71.11% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 19.10% during the next five years compared to -585.84% drop over the previous five years of trading.
Clover Health Investments Corp (NASDAQ: CLOV) Trading Performance Indicators
Take a look at Clover Health Investments Corp’s (CLOV) current performance indicators. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.77.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.26, a number that is poised to hit -0.04 in the next quarter and is forecasted to reach -0.12 in one year’s time.
Technical Analysis of Clover Health Investments Corp (CLOV)
Clover Health Investments Corp (NASDAQ: CLOV) saw its 5-day average volume 11.31 million, a positive change from its year-to-date volume of 8.01 million. As of the previous 9 days, the stock’s Stochastic %D was 17.76%. Additionally, its Average True Range was 0.30.
During the past 100 days, Clover Health Investments Corp’s (CLOV) raw stochastic average was set at 63.07%, which indicates a significant increase from 39.07% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 134.69% in the past 14 days, which was higher than the 94.89% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.96, while its 200-day Moving Average is $1.17. Nevertheless, the first resistance level for the watch stands at $2.79 in the near term. At $2.96, the stock is likely to face the second major resistance level. The third major resistance level sits at $3.08. If the price goes on to break the first support level at $2.50, it is likely to go to the next support level at $2.38. Assuming the price breaks the second support level, the third support level stands at $2.21.
Clover Health Investments Corp (NASDAQ: CLOV) Key Stats
The company with the Market Capitalisation of 1.31 billion has total of 496,437K Shares Outstanding. Its annual sales at the moment are 2,034 M in contrast with the sum of -213,360 K annual income. Company’s last quarter sales were recorded 356,260 K and last quarter income was 7,410 K.
